Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis
- 23 September 2009
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 158 (4) , 607-614
- https://doi.org/10.1016/j.ahj.2009.08.006
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Homozygous Transthyretin Mutation in an African American MaleThe Journal of Molecular Diagnostics, 2007
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005
- Senile Systemic Amyloidosis Presenting With Heart FailureArchives of internal medicine (1960), 2005
- A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American populationAmyloid, 2005
- High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year StudyAnnals of Internal Medicine, 2004
- Tabulation of human transthyretin (TTR) variants, 2003Amyloid, 2003
- Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black AmericansNew England Journal of Medicine, 1997
- Revised transthyretin Ile 122 allele frequency in African-AmericansHuman Genetics, 1996
- Cardiac Amyloidosis: Report of a Patient Heterozygous for the Transthyretin Isoleucine 122 VariantScandinavian Journal of Immunology, 1990
- Fibril in senile systemic amyloidosis is derived from normal transthyretin.Proceedings of the National Academy of Sciences, 1990